Biocon Claims Edge For Adalimumab In US

Cites Encouraging Payer Discussions Over Humira Biosimilar

Biocon logo under magnifying glass
Biocon Well Placed To Debut Humira Biosimilar In The US • Source: Postmodern Studio / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products